Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)
Identifieur interne : 001811 ( Pmc/Corpus ); précédent : 001810; suivant : 001812Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)
Auteurs : Lindsay M. Morton ; Jennifer J. Turner ; James R. Cerhan ; Martha S. Linet ; Patrick A. Treseler ; Christina A. Clarke ; Andrew Jack ; Wendy Cozen ; Marc Maynadié ; John J. Spinelli ; Adele Seniori Costantini ; Thomas Rüdiger ; Aldo Scarpa ; Tongzhang Zheng ; Dennis D. WeisenburgerSource :
- Blood [ 0006-4971 ] ; 2007.
Abstract
Recent evidence suggests that there is etiologic heterogeneity among the various subtypes of lymphoid neoplasms. However, epidemiologic analyses by disease subtype have proven challenging due to the numerous clinical and pathologic schemes used to classify lymphomas and lymphoid leukemias over the last several decades. On behalf of the International Lymphoma Epidemiology Consortium (InterLymph) Pathology Working Group, we present a proposed nested classification of lymphoid neoplasms to facilitate the analysis of lymphoid neoplasm subtypes in epidemiologic research. The proposed classification is based on the World Health Organization classification of lymphoid neoplasms and the International Classification of Diseases–Oncology, Third Edition (ICD-O-3). We also provide a translation into the proposed classification from previous classifications, including the Working Formulation, Revised European-American Lymphoma (REAL) classification, and ICD-O-2. We recommend that epidemiologic studies include analyses by lymphoma subtype to the most detailed extent allowable by sample size. The standardization of groupings for epidemiologic research of lymphoma subtypes is essential for comparing subtype-specific reports in the literature, harmonizing cases within a single study diagnosed using different systems, as well as combining data from multiple studies for the purpose of pooled analysis or meta-analysis, and will probably prove to be critical for elucidating etiologies of the various lymphoid neoplasms.
Url:
DOI: 10.1182/blood-2006-11-051672
PubMed: 17389762
PubMed Central: 1924473
Links to Exploration step
PMC:1924473Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)</title><author><name sortKey="Morton, Lindsay M" sort="Morton, Lindsay M" uniqKey="Morton L" first="Lindsay M." last="Morton">Lindsay M. Morton</name><affiliation><nlm:aff id="aff1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD;</nlm:aff></affiliation></author><author><name sortKey="Turner, Jennifer J" sort="Turner, Jennifer J" uniqKey="Turner J" first="Jennifer J." last="Turner">Jennifer J. Turner</name><affiliation><nlm:aff id="aff2">Department of Anatomical Pathology, St Vincent's Hospital, New South Wales, Australia;</nlm:aff></affiliation></author><author><name sortKey="Cerhan, James R" sort="Cerhan, James R" uniqKey="Cerhan J" first="James R." last="Cerhan">James R. Cerhan</name><affiliation><nlm:aff id="aff3">Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN;</nlm:aff></affiliation></author><author><name sortKey="Linet, Martha S" sort="Linet, Martha S" uniqKey="Linet M" first="Martha S." last="Linet">Martha S. Linet</name><affiliation><nlm:aff id="aff1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD;</nlm:aff></affiliation></author><author><name sortKey="Treseler, Patrick A" sort="Treseler, Patrick A" uniqKey="Treseler P" first="Patrick A." last="Treseler">Patrick A. Treseler</name><affiliation><nlm:aff id="aff4">Department of Pathology, University of California at San Francisco, CA;</nlm:aff></affiliation></author><author><name sortKey="Clarke, Christina A" sort="Clarke, Christina A" uniqKey="Clarke C" first="Christina A." last="Clarke">Christina A. Clarke</name><affiliation><nlm:aff id="aff5">Northern California Cancer Center, Fremont;</nlm:aff></affiliation></author><author><name sortKey="Jack, Andrew" sort="Jack, Andrew" uniqKey="Jack A" first="Andrew" last="Jack">Andrew Jack</name><affiliation><nlm:aff id="aff6">Haematological Malignancy Diagnostic Service, Department of Haematology, Leeds Teaching Hospital, National Health Service (NHS) Trust, Leeds, United Kingdom;</nlm:aff></affiliation></author><author><name sortKey="Cozen, Wendy" sort="Cozen, Wendy" uniqKey="Cozen W" first="Wendy" last="Cozen">Wendy Cozen</name><affiliation><nlm:aff id="aff7">Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles;</nlm:aff></affiliation></author><author><name sortKey="Maynadie, Marc" sort="Maynadie, Marc" uniqKey="Maynadie M" first="Marc" last="Maynadié">Marc Maynadié</name><affiliation><nlm:aff id="aff8">Haematology Laboratory, University Hospital, Dijon, France;</nlm:aff></affiliation></author><author><name sortKey="Spinelli, John J" sort="Spinelli, John J" uniqKey="Spinelli J" first="John J." last="Spinelli">John J. Spinelli</name><affiliation><nlm:aff id="aff9">British Columbia Cancer Agency, Vancouver, BC, Canada;</nlm:aff></affiliation></author><author><name sortKey="Costantini, Adele Seniori" sort="Costantini, Adele Seniori" uniqKey="Costantini A" first="Adele Seniori" last="Costantini">Adele Seniori Costantini</name><affiliation><nlm:aff id="aff10">Occupational and Environmental Epidemiology Unit, Center for Study and Prevention of Cancer, Scientific Institute of Tuscany, Florence, Italy;</nlm:aff></affiliation></author><author><name sortKey="Rudiger, Thomas" sort="Rudiger, Thomas" uniqKey="Rudiger T" first="Thomas" last="Rüdiger">Thomas Rüdiger</name><affiliation><nlm:aff id="aff11">Institute of Pathology, University of Wurzburg, Germany;</nlm:aff></affiliation></author><author><name sortKey="Scarpa, Aldo" sort="Scarpa, Aldo" uniqKey="Scarpa A" first="Aldo" last="Scarpa">Aldo Scarpa</name><affiliation><nlm:aff id="aff12">Department of Pathology, University of Verona, Ospedale Policlinico, Verona, Italy;</nlm:aff></affiliation></author><author><name sortKey="Zheng, Tongzhang" sort="Zheng, Tongzhang" uniqKey="Zheng T" first="Tongzhang" last="Zheng">Tongzhang Zheng</name><affiliation><nlm:aff wicri:cut="; and" id="aff13">Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT</nlm:aff></affiliation></author><author><name sortKey="Weisenburger, Dennis D" sort="Weisenburger, Dennis D" uniqKey="Weisenburger D" first="Dennis D." last="Weisenburger">Dennis D. Weisenburger</name><affiliation><nlm:aff id="aff14">Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">17389762</idno><idno type="pmc">1924473</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924473</idno><idno type="RBID">PMC:1924473</idno><idno type="doi">10.1182/blood-2006-11-051672</idno><date when="2007">2007</date><idno type="wicri:Area/Pmc/Corpus">001811</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001811</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)</title><author><name sortKey="Morton, Lindsay M" sort="Morton, Lindsay M" uniqKey="Morton L" first="Lindsay M." last="Morton">Lindsay M. Morton</name><affiliation><nlm:aff id="aff1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD;</nlm:aff></affiliation></author><author><name sortKey="Turner, Jennifer J" sort="Turner, Jennifer J" uniqKey="Turner J" first="Jennifer J." last="Turner">Jennifer J. Turner</name><affiliation><nlm:aff id="aff2">Department of Anatomical Pathology, St Vincent's Hospital, New South Wales, Australia;</nlm:aff></affiliation></author><author><name sortKey="Cerhan, James R" sort="Cerhan, James R" uniqKey="Cerhan J" first="James R." last="Cerhan">James R. Cerhan</name><affiliation><nlm:aff id="aff3">Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN;</nlm:aff></affiliation></author><author><name sortKey="Linet, Martha S" sort="Linet, Martha S" uniqKey="Linet M" first="Martha S." last="Linet">Martha S. Linet</name><affiliation><nlm:aff id="aff1">Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD;</nlm:aff></affiliation></author><author><name sortKey="Treseler, Patrick A" sort="Treseler, Patrick A" uniqKey="Treseler P" first="Patrick A." last="Treseler">Patrick A. Treseler</name><affiliation><nlm:aff id="aff4">Department of Pathology, University of California at San Francisco, CA;</nlm:aff></affiliation></author><author><name sortKey="Clarke, Christina A" sort="Clarke, Christina A" uniqKey="Clarke C" first="Christina A." last="Clarke">Christina A. Clarke</name><affiliation><nlm:aff id="aff5">Northern California Cancer Center, Fremont;</nlm:aff></affiliation></author><author><name sortKey="Jack, Andrew" sort="Jack, Andrew" uniqKey="Jack A" first="Andrew" last="Jack">Andrew Jack</name><affiliation><nlm:aff id="aff6">Haematological Malignancy Diagnostic Service, Department of Haematology, Leeds Teaching Hospital, National Health Service (NHS) Trust, Leeds, United Kingdom;</nlm:aff></affiliation></author><author><name sortKey="Cozen, Wendy" sort="Cozen, Wendy" uniqKey="Cozen W" first="Wendy" last="Cozen">Wendy Cozen</name><affiliation><nlm:aff id="aff7">Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles;</nlm:aff></affiliation></author><author><name sortKey="Maynadie, Marc" sort="Maynadie, Marc" uniqKey="Maynadie M" first="Marc" last="Maynadié">Marc Maynadié</name><affiliation><nlm:aff id="aff8">Haematology Laboratory, University Hospital, Dijon, France;</nlm:aff></affiliation></author><author><name sortKey="Spinelli, John J" sort="Spinelli, John J" uniqKey="Spinelli J" first="John J." last="Spinelli">John J. Spinelli</name><affiliation><nlm:aff id="aff9">British Columbia Cancer Agency, Vancouver, BC, Canada;</nlm:aff></affiliation></author><author><name sortKey="Costantini, Adele Seniori" sort="Costantini, Adele Seniori" uniqKey="Costantini A" first="Adele Seniori" last="Costantini">Adele Seniori Costantini</name><affiliation><nlm:aff id="aff10">Occupational and Environmental Epidemiology Unit, Center for Study and Prevention of Cancer, Scientific Institute of Tuscany, Florence, Italy;</nlm:aff></affiliation></author><author><name sortKey="Rudiger, Thomas" sort="Rudiger, Thomas" uniqKey="Rudiger T" first="Thomas" last="Rüdiger">Thomas Rüdiger</name><affiliation><nlm:aff id="aff11">Institute of Pathology, University of Wurzburg, Germany;</nlm:aff></affiliation></author><author><name sortKey="Scarpa, Aldo" sort="Scarpa, Aldo" uniqKey="Scarpa A" first="Aldo" last="Scarpa">Aldo Scarpa</name><affiliation><nlm:aff id="aff12">Department of Pathology, University of Verona, Ospedale Policlinico, Verona, Italy;</nlm:aff></affiliation></author><author><name sortKey="Zheng, Tongzhang" sort="Zheng, Tongzhang" uniqKey="Zheng T" first="Tongzhang" last="Zheng">Tongzhang Zheng</name><affiliation><nlm:aff wicri:cut="; and" id="aff13">Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT</nlm:aff></affiliation></author><author><name sortKey="Weisenburger, Dennis D" sort="Weisenburger, Dennis D" uniqKey="Weisenburger D" first="Dennis D." last="Weisenburger">Dennis D. Weisenburger</name><affiliation><nlm:aff id="aff14">Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha</nlm:aff></affiliation></author></analytic><series><title level="j">Blood</title><idno type="ISSN">0006-4971</idno><idno type="eISSN">1528-0020</idno><imprint><date when="2007">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Recent evidence suggests that there is etiologic heterogeneity among the various subtypes of lymphoid neoplasms. However, epidemiologic analyses by disease subtype have proven challenging due to the numerous clinical and pathologic schemes used to classify lymphomas and lymphoid leukemias over the last several decades. On behalf of the International Lymphoma Epidemiology Consortium (InterLymph) Pathology Working Group, we present a proposed nested classification of lymphoid neoplasms to facilitate the analysis of lymphoid neoplasm subtypes in epidemiologic research. The proposed classification is based on the World Health Organization classification of lymphoid neoplasms and the International Classification of Diseases–Oncology, Third Edition (ICD-O-3). We also provide a translation into the proposed classification from previous classifications, including the Working Formulation, Revised European-American Lymphoma (REAL) classification, and ICD-O-2. We recommend that epidemiologic studies include analyses by lymphoma subtype to the most detailed extent allowable by sample size. The standardization of groupings for epidemiologic research of lymphoma subtypes is essential for comparing subtype-specific reports in the literature, harmonizing cases within a single study diagnosed using different systems, as well as combining data from multiple studies for the purpose of pooled analysis or meta-analysis, and will probably prove to be critical for elucidating etiologies of the various lymphoid neoplasms.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Blood</journal-id><journal-id journal-id-type="publisher-id">Blood</journal-id><journal-title>Blood</journal-title><issn pub-type="ppub">0006-4971</issn><issn pub-type="epub">1528-0020</issn><publisher><publisher-name>American Society of Hematology</publisher-name> <publisher-loc>Washington, DC</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">17389762</article-id><article-id pub-id-type="pmc">1924473</article-id><article-id pub-id-type="publisher-id">2006/051672</article-id><article-id pub-id-type="doi">10.1182/blood-2006-11-051672</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neoplasia</subject></subj-group><series-title>Neoplasia</series-title></article-categories><title-group><article-title>Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Morton</surname><given-names>Lindsay M.</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Turner</surname><given-names>Jennifer J.</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Cerhan</surname><given-names>James R.</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Linet</surname><given-names>Martha S.</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Treseler</surname><given-names>Patrick A.</given-names></name><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Clarke</surname><given-names>Christina A.</given-names></name><xref rid="aff5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Jack</surname><given-names>Andrew</given-names></name><xref rid="aff6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name><surname>Cozen</surname><given-names>Wendy</given-names></name><xref rid="aff7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name><surname>Maynadié</surname><given-names>Marc</given-names></name><xref rid="aff8" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name><surname>Spinelli</surname><given-names>John J.</given-names></name><xref rid="aff9" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><name><surname>Costantini</surname><given-names>Adele Seniori</given-names></name><xref rid="aff10" ref-type="aff">10</xref></contrib><contrib contrib-type="author"><name><surname>Rüdiger</surname><given-names>Thomas</given-names></name><xref rid="aff11" ref-type="aff">11</xref></contrib><contrib contrib-type="author"><name><surname>Scarpa</surname><given-names>Aldo</given-names></name><xref rid="aff12" ref-type="aff">12</xref></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Tongzhang</given-names></name><xref rid="aff13" ref-type="aff">13</xref></contrib><contrib contrib-type="author"><name><surname>Weisenburger</surname><given-names>Dennis D.</given-names></name><xref rid="aff14" ref-type="aff">14</xref></contrib><aff id="aff1"><label>1</label>Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD;</aff><aff id="aff2"><label>2</label>Department of Anatomical Pathology, St Vincent's Hospital, New South Wales, Australia;</aff><aff id="aff3"><label>3</label>Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN;</aff><aff id="aff4"><label>4</label>Department of Pathology, University of California at San Francisco, CA;</aff><aff id="aff5"><label>5</label>Northern California Cancer Center, Fremont;</aff><aff id="aff6"><label>6</label>Haematological Malignancy Diagnostic Service, Department of Haematology, Leeds Teaching Hospital, National Health Service (NHS) Trust, Leeds, United Kingdom;</aff><aff id="aff7"><label>7</label>Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles;</aff><aff id="aff8"><label>8</label>Haematology Laboratory, University Hospital, Dijon, France;</aff><aff id="aff9"><label>9</label>British Columbia Cancer Agency, Vancouver, BC, Canada;</aff><aff id="aff10"><label>10</label>Occupational and Environmental Epidemiology Unit, Center for Study and Prevention of Cancer, Scientific Institute of Tuscany, Florence, Italy;</aff><aff id="aff11"><label>11</label>Institute of Pathology, University of Wurzburg, Germany;</aff><aff id="aff12"><label>12</label>Department of Pathology, University of Verona, Ospedale Policlinico, Verona, Italy;</aff><aff id="aff13"><label>13</label>Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT; and</aff><aff id="aff14"><label>14</label>Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha</aff></contrib-group><pub-date pub-type="ppub"><day>15</day><month>7</month><year>2007</year></pub-date><pub-date pub-type="epreprint"><day>27</day><month>3</month><year>2007</year></pub-date><pub-date pub-type="pmc-release"><day>15</day><month>7</month><year>2008</year></pub-date><volume>110</volume><issue>2</issue><fpage>695</fpage><lpage>708</lpage><history><date date-type="received"><day>2</day><month>11</month><year>2006</year></date><date date-type="accepted"><day>10</day><month>3</month><year>2007</year></date></history><copyright-statement>© 2007 by The American Society of Hematology</copyright-statement><copyright-year>2007</copyright-year><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zh801407000695.pdf"></self-uri><abstract><p>Recent evidence suggests that there is etiologic heterogeneity among the various subtypes of lymphoid neoplasms. However, epidemiologic analyses by disease subtype have proven challenging due to the numerous clinical and pathologic schemes used to classify lymphomas and lymphoid leukemias over the last several decades. On behalf of the International Lymphoma Epidemiology Consortium (InterLymph) Pathology Working Group, we present a proposed nested classification of lymphoid neoplasms to facilitate the analysis of lymphoid neoplasm subtypes in epidemiologic research. The proposed classification is based on the World Health Organization classification of lymphoid neoplasms and the International Classification of Diseases–Oncology, Third Edition (ICD-O-3). We also provide a translation into the proposed classification from previous classifications, including the Working Formulation, Revised European-American Lymphoma (REAL) classification, and ICD-O-2. We recommend that epidemiologic studies include analyses by lymphoma subtype to the most detailed extent allowable by sample size. The standardization of groupings for epidemiologic research of lymphoma subtypes is essential for comparing subtype-specific reports in the literature, harmonizing cases within a single study diagnosed using different systems, as well as combining data from multiple studies for the purpose of pooled analysis or meta-analysis, and will probably prove to be critical for elucidating etiologies of the various lymphoid neoplasms.</p></abstract><contract-sponsor id="CS100" xlink:href="http://www.nih.gov">National Institutes of Health</contract-sponsor></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001811 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 001811 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:1924473
|texte= Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:17389762" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |